Puma Biotechnology Inc (PBYI) financial statements (2020 and earlier)

Company profile

Business Address 10880 WILSHIRE BLVD.
LOS ANGELES, CA 90024
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:1121658222921614184
Cash and cash equivalents6010882194323943
Short-term investments5257 3518410341
Other undisclosed cash, cash equivalents, and short-term investments  0(0)   
Restricted cash and investments9    1 
Receivables292110  2 
Inventory, net of allowances, customer advances and progress billings332   
Inventory332    
Prepaid expense13      
Deferred rent asset0      
Other current assets02     
Other undisclosed current assets 121378512
Total current assets:16620310623622414996
Noncurrent Assets
Operating lease, right-of-use asset19
Property, plant and equipment3445222
Intangible assets, net (including goodwill)404448   
Intangible assets, net (excluding goodwill)404448    
Restricted cash and investments44444  
Other undisclosed noncurrent assets232710116
Total noncurrent assets:6956591616138
TOTAL ASSETS:235259166253240163104
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities88675837324720
Accounts payable19212820181511
Accrued liabilities6946311715299
Employee-related liabilities     21
Debt3      
Other undisclosed current liabilities     (2)(1)
Total current liabilities:91675837324419
Noncurrent Liabilities
Long-term debt and lease obligation23      
Operating lease, liability23
Liabilities, other than long-term debt 656111
Deferred revenue and credits56111
Deferred rent credit 6
Other undisclosed noncurrent liabilities10415248    
Total noncurrent liabilities:127158546111
Total liabilities:21722511243344620
Stockholders' equity
Stockholders' equity attributable to parent, including:17345321020611784
Common stock0000000
Additional paid in capital1,2951,2361,1421,006727399223
Accumulated other comprehensive income (loss)0(0) (0)(0)(0)0
Accumulated deficit(1,278)(1,202)(1,088)(797)(521)(281) 
Receivable from shareholders or affiliates for issuance of capital stock  (0)  (1) 
Other undisclosed stockholders' equity attributable to parent      (139)
Total stockholders' equity:17345321020611784
TOTAL LIABILITIES AND EQUITY:235259166253240163104

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues27225128    
Revenue, net28(3)(0)  
Cost of revenue
(Cost of Goods and Services Sold)
 (35)(6)   (16)
Gross profit:27221622   (16)
Operating expenses(311)(346)(320)(277)(240)(142)(55)
Other undisclosed operating income 35630 16
Operating loss:(39)(95)(292)(277)(240)(142)(55)
Nonoperating income (expense)(36)(19)01100
Investment income, nonoperating3211100
Other nonoperating income (expense)0(1)(0)(0)0(0)0
Interest and debt expense(8)(0)(1)    
Loss from continuing operations before income taxes:(84)(114)(293)(276)(239)(142)(55)
Income tax expense(0)(0)     
Loss before gain (loss) on sale of properties:(84)(114)(293)(276)(239)(142)(55)
Other undisclosed net income80     
Net loss:(76)(114)(293)(276)(239)(142)(55)
Other undisclosed net income attributable to parent  1    
Net loss available to common stockholders, diluted:(76)(114)(292)(276)(239)(142)(55)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(76)(114)(293)(276)(239)(142)(55)
Comprehensive loss:(76)(114)(293)(276)(239)(142)(55)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)10(0)(0)0
Comprehensive loss, net of tax, attributable to parent:(76)(114)(292)(276)(239)(142)(55)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: